Semler Scientific, Inc.

    Jurisdiction
    United States
    LEI
    549300ZHL16S29QTW485
    ISIN
    US81684M1045 (SMLR)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    49 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. Read full profile

    Fundamentals

    Net revenue
    €36.66M
    Gross margin
    90.8%
    EBIT
    -€20.94M
    EBIT margin
    -57.1%
    Net income
    €31.60M
    Net margin
    86.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €23.11M -36.9% -€10.39M -132.9%
    €13.31M -42.4% -€26.54M +155.4%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Murphy-Chutorian Douglas Chief Executive Officer -29K $30.54 -$873.57K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Bill Miller 53K $1.92M +10K Buy

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications